The stock has a 36-month beta value of 1.41. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 1 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for ELAN is 488.20M, and at present, short sellers hold a 2.36% of that float. On October 29, 2024, the average trading volume of ELAN was 4.70M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ELAN) stock’s latest price update
Elanco Animal Health Inc (NYSE: ELAN)’s stock price has soared by 0.81 in relation to previous closing price of 12.41. Nevertheless, the company has seen a loss of -0.87% in its stock price over the last five trading days. accesswire.com reported 2024-10-28 that NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=109775&wire=1 or contact Joseph E. Levi, Esq.
ELAN’s Market Performance
Elanco Animal Health Inc (ELAN) has experienced a -0.87% fall in stock performance for the past week, with a -12.64% drop in the past month, and a -3.02% drop in the past quarter. The volatility ratio for the week is 2.60%, and the volatility levels for the past 30 days are at 3.29% for ELAN. The simple moving average for the past 20 days is -8.38% for ELAN’s stock, with a -16.72% simple moving average for the past 200 days.
Analysts’ Opinion of ELAN
Many brokerage firms have already submitted their reports for ELAN stocks, with Morgan Stanley repeating the rating for ELAN by listing it as a “Equal-Weight.” The predicted price for ELAN in the upcoming period, according to Morgan Stanley is $15 based on the research report published on September 19, 2024 of the current year 2024.
Stifel, on the other hand, stated in their research note that they expect to see ELAN reach a price target of $20, previously predicting the price at $13. The rating they have provided for ELAN stocks is “Buy” according to the report published on January 05th, 2024.
Jefferies gave a rating of “Buy” to ELAN, setting the target price at $17 in the report published on December 19th of the previous year.
ELAN Trading at -12.26% from the 50-Day Moving Average
After a stumble in the market that brought ELAN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.46% of loss for the given period.
Volatility was left at 3.29%, however, over the last 30 days, the volatility rate increased by 2.60%, as shares sank -14.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.66% lower at present.
During the last 5 trading sessions, ELAN fell by -0.87%, which changed the moving average for the period of 200-days by -19.24% in comparison to the 20-day moving average, which settled at $13.65. In addition, Elanco Animal Health Inc saw -16.04% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELAN starting from Harrington Michael J, who purchase 3,500 shares at the price of $14.85 back on Aug 22 ’24. After this action, Harrington Michael J now owns 81,094 shares of Elanco Animal Health Inc, valued at $51,974 using the latest closing price.
Simmons Jeffrey N, the PRESIDENT, CEO AND DIRECTOR of Elanco Animal Health Inc, purchase 100,000 shares at $13.01 during a trade that took place back on Aug 12 ’24, which means that Simmons Jeffrey N is holding 145,000 shares at $1,300,610 based on the most recent closing price.
Stock Fundamentals for ELAN
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.52 for the gross margin
The net margin for Elanco Animal Health Inc stands at -0.28. The total capital return value is set at 0.02. Equity return is now at value -18.78, with -8.49 for asset returns.
Based on Elanco Animal Health Inc (ELAN), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at 0.1. The debt to equity ratio resting at 0.96. The interest coverage ratio of the stock is 0.99.
Currently, EBITDA for the company is 945.0 million with net debt to EBITDA at 5.93. When we switch over and look at the enterprise to sales, we see a ratio of 2.55. The receivables turnover for the company is 4.16for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.93.
Conclusion
To sum up, Elanco Animal Health Inc (ELAN) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
